Cell cycle analysis at 72 h (Fig. 3Bi-iii) revealed CP-CML CD34+ cells were affected by inhibition with DOR alone or in combination with a TKI. This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.